Skip to main content
HealixMedical Supply

Cardiac Rehabilitation: Evidence, Utilization Gaps, and Clinical Benefits After MI and Heart Failure

By Healix Editorial Team·May 27, 2026·5 min read

Evidence-based guide to cardiac rehabilitation — survival benefits post-MI and heart failure, the significant utilization gap, supervised vs. home-based CR, and barriers to enrollment and completion.

Cardiac rehabilitation (CR) — a medically supervised program combining exercise training, cardiovascular risk factor management, nutritional counseling, and psychosocial support — is one of the most evidence-supported interventions in cardiology, yet one of the most consistently underutilized. Eligible patients who participate in CR have 26% lower all-cause mortality and 31% lower cardiovascular mortality versus non-participants — effect sizes that exceed most pharmacological interventions — yet only 20–30% of eligible patients enroll.

Evidence: Who Benefits and How Much

Post-MI and revascularization: the CR evidence base is strongest here. Cochrane meta-analysis (Taylor et al., 2019, 85 RCTs, n=23,430): exercise-based CR significantly reduces cardiovascular mortality (RR 0.74), total hospitalizations (RR 0.82), and improves quality of life versus no CR. The mortality benefit is most pronounced in patients at higher baseline risk. Current ACC/AHA guidelines: Class I indication (strongest recommendation) for CR enrollment after acute MI, CABG, PCI, stable angina, and stable heart failure. Heart failure with reduced ejection fraction (HFrEF): HF-ACTION trial (n=2,331): supervised aerobic exercise significantly reduced all-cause hospitalization and cardiovascular mortality after 2.5 years. Multiple meta-analyses confirm CR reduces hospitalizations by 25% and improves VO₂max and quality of life in HFrEF. Home-based CR: virtually equivalent outcomes to center-based CR for stable patients (REACH-HF trial, CROLP trial) — home-based programs dramatically improve access for patients with transportation, employment, or disability barriers to center attendance. Wearable-guided home CR programs are an emerging evidence-based approach.

The Utilization Gap

Despite overwhelming evidence, 70–80% of eligible patients don't enroll in CR. Barriers: patient factors (lack of awareness, transportation, employment, cost, disability), provider factors (failure to refer — <60% of eligible patients receive a CR referral), and system factors (insufficient program capacity). Evidence-based solutions: automatic referral order sets at hospital discharge (proven to increase referral rates from 30% to 70%), nurse-led facilitated enrollment, and telehealth CR models. For clinical cardiac care facilities and hospitals, our diagnostic equipment catalog includes blood pressure monitors, pulse oximeters, and ECG supplies essential for cardiac rehabilitation monitoring, and our PPE section ensures appropriate infection control in rehabilitation settings.

Medical disclaimer: This article is for general informational purposes only and is not medical advice. Consult a qualified healthcare provider before making decisions about your health or care. Read our editorial policy to learn how this content is researched and reviewed.

Topics:

cardiac rehabilitation evidence 2025cardiac rehab post-MI mortality benefitheart failure cardiac rehabilitation evidencecardiac rehab utilization gap clinicalCR program home-based supervised comparison

Need Clinical-Grade Medical Supplies?

Healix Medical Supply stocks 1.5 Million+ FDA-cleared products with bulk pricing for healthcare facilities nationwide.